Phillyrin ameliorates influenza a virus-induced pulmonary inflammation by antagonizing CXCR2 and inhibiting NLRP3 inflammasome activation

Influenza is an acute viral respiratory illness with high morbidity rates worldwide. Excessive pulmonary inflammation is the main characteristic of lethal influenza A virus (IAV) infections. Therapeutic options for managing influenza are limited to vaccines and some antiviral medications. Phillyrin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shanyu, Sun, Fengzhi, Zhu, Jinlu, Qi, Jianhong, Wang, Wenjing, Liu, Ziming, Li, Wenqian, Liu, Chuanguo, Liu, Xuehuan, Wang, Nonghan, Song, Xinyu, Zhang, Dan, Qi, Dongmei, Wang, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644626/
https://www.ncbi.nlm.nih.gov/pubmed/37957672
http://dx.doi.org/10.1186/s12985-023-02219-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644626/
https://www.ncbi.nlm.nih.gov/pubmed/37957672
http://dx.doi.org/10.1186/s12985-023-02219-4

Ejemplares similares